300073164617

The barcode 300073164617 corresponds to Smith Kline French Labs, specifically for their AvandiaMet tablets, which contain 4 mg of metformin hydrochloride combined with an extended-release formulation of metformin. AvandiaMet is used primarily for the management of type 2 diabetes and functions by improving insulin sensitivity and decreasing glucose production in the liver.

While there are no specific warnings or concerns that apply solely to AvandiaMet, it is important to be aware of the potential side effects associated with metformin. Common side effects can include gastrointestinal symptoms such as diarrhea, nausea, and abdominal discomfort. More severe, but less common, side effects include lactic acidosis, which poses a significant risk for certain populations, particularly those with impaired kidney or liver functions.

Pricing for AvandiaMet can vary widely, often ranging from $50 to $150 for a 30-day supply depending on various factors such as the pharmacy, geographic location, and insurance coverage.

In 2012, the FDA mandated the addition of a black box warning for metformin-containing products, which highlights the risk of lactic acidosis, especially in individuals with specific health conditions. However, this warning does not apply exclusively to AvandiaMet and is relevant to metformin generally.

Given its status as a consumable product, there are no specific health-related disclaimers unique to AvandiaMet beyond standard precautions applicable to medications. Always consult with a healthcare provider for professional medical advice tailored to individual health needs.